Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. (CNCE) Stock Overview
Explore Concert Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-3.49
EPS (TTM)
$-3.17
ROE
-0.68%
CNCE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Concert Pharmaceuticals, Inc. (CNCE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $24.59.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.49 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.